on 8 Jan 2025
Last Applicant/ Owned by
Impact Biomedicines, Inc.
86 Morris AvenueSummit, NJ 07901
US
Serial Number
2113386 filed on 10th Jun 2021
Correspondent Address
GOWLING WLG (CANADA) LLP
SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO
ONTARIO
CA
M5X1G5
Trademark usage description
pharmaceutical preparations for use in the treatment of myeloproliferative diseases, myelofibrosis, autoinflammatory disease, autoimmune disease, bloo Read MoreVienna Information
26 . 15 . 13
PrismsPrismes
26 . 15 . 25
Other geometrical solidsAutres corps géométriques
24 . 15 . 21
Arrowheads -- Note: Not including arrowheads in the form of angles (26.3.23).Pointes de flèches -- Note: Non compris les pointes de flèches en forme d'angles (26.3.23).
25 . 7 . 1
Surfaces or backgrounds covered with repeated geometrical figures or designsSurfaces ou fonds couverts de figures ou de motifs géométriques répétés
25 . 7 . 3
Surfaces or backgrounds covered with squares or rectangles (except a 25.7.4)Surfaces ou fonds couverts de carrés ou de rectangles (excepté a 25.7.4)
29 . 1 . 4
BlueBleu
29 . 1 . 6
White, grey, silverBlanc, gris, argent
11
2113386
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 42 on 8th Jan 2025 | Advertised |
Submitted for opposition 26 on 16th Dec 2024 | Approved |
Submitted for opposition 27 on 16th Dec 2024 | Approval Notice Sent |
Submitted for opposition 22 on 6th Dec 2024 | Search Recorded |
Submitted for opposition 287 on 5th Jul 2022 | Pre-Assessment Letter Sent |
Submitted for opposition 30 on 10th Jun 2021 | Filed |
Submitted for opposition 1 on 10th Jun 2021 | Created |
Submitted for opposition 31 on 10th Jun 2021 | Formalized |